Pioneering British scientist whose work could save millions dies aged 29

The world has lost a remarkable scientist and visionary at the young age of 29, as reported by Sky News on Monday, 09 October 2023. Dr. Kirsty Smitten, renowned for her groundbreaking work in developing antibiotics to combat antimicrobial resistance (AMR), passed away on 4th October after a courageous battle with cardiac angiosarcoma. Her legacy extends far beyond her scientific contributions, encompassing her determination, resilience, and altruistic nature.

Dr. Kirsty Smitten’s journey was marked by brilliance and compassion. As a co-founder and chief executive of MetalloBio, she spearheaded research aimed at creating new antibiotics to address the global threat of AMR. Her achievements earned her a well-deserved spot on Forbes’ 30 under 30 Europe list in 2020, a testament to her dedication and impact.

However, Kirsty’s promising career was tragically cut short when she was diagnosed with cardiac angiosarcoma in late January. Despite the bleak prognosis, she continued her work even when faced with the most challenging circumstances.

Kirsty’s commitment to combating AMR and saving lives was unwavering. Her brother, Matt Smitten, described her as “determined, resilient, and caring.” Despite recognizing that her chosen path might not bring her personal riches, Kirsty believed it was where she could have the most significant impact. Her altruism shone brightly, illuminating her dedication to helping as many people as possible.

Through her company, MetalloBio, Kirsty Smitten pursued the development of two lead compounds designed to counter AMR. This mission is of critical importance, as AMR is responsible for 1.2 million deaths annually worldwide and has been designated an “urgent priority” by the World Health Organization. Kirsty’s work will undoubtedly continue to benefit countless lives.

Despite the grueling challenges posed by her diagnosis and subsequent treatment, Kirsty’s tenacity prevailed. She continued to work tirelessly, even as she underwent chemotherapy. Her sister-in-law, Sukhi Smitten, attested to Kirsty’s unwavering commitment, highlighting that she was pitching for grants and pushing research forward while battling to breathe and walk.

Kirsty’s compassion extended beyond her professional pursuits. Her own cancer diagnosis became a catalyst for supporting other cancer patients in their journeys. She reached out to those facing similar challenges, offering guidance and understanding. Kirsty’s impact on these individuals was profound, even if she remained humble about her contributions.

Kirsty’s family aims to ensure her legacy endures through MetalloBio and a charity they plan to establish in her name. They have initiated a fundraiser to support this endeavor. Her social media accounts on Instagram and TikTok, where she candidly shared information about her disease, remain accessible as valuable resources for those seeking knowledge about cardiac angiosarcoma.

The world has lost an extraordinary scientist, a compassionate soul, and an inspiration to many. Dr. Kirsty Smitten’s determination, resilience, and unwavering altruism serve as a beacon of hope and a reminder of the remarkable impact one individual can have. Her work in the fight against antimicrobial resistance will continue to save lives, and her legacy will endure through the charitable endeavors championed by her family. Kirsty’s story is a testament to the power of science, compassion, and the enduring human spirit.